Skip to main content
Erschienen in: BMC Public Health 1/2024

Open Access 01.12.2024 | Research

Common carotid artery diameter and the risk of cardiovascular disease mortality: a prospective cohort study in northeast China

verfasst von: Ziyi Yin, Jiajing Guo, Ru Li, Hong Zhou, Xue Zhang, Shanshan Guan, Yuanmeng Tian, Li Jing, Qun Sun, Guangxiao Li, Liying Xing, Shuang Liu

Erschienen in: BMC Public Health | Ausgabe 1/2024

Abstract

Background

The association between the common carotid artery (CCA) diameter and cardiovascular disease (CVD) is recognized, but the precise nature of this link remains elusive. This study aimed to investigate the potential relationship between CCA diameter and the risk of CVD mortality in a large population in northeast China.

Methods

The current study included 5668 participants (mean age 58.9 ± 10.1 years) from a population-based study conducted in rural areas of northeast China between September 2017 and May 2018. Information on death was collected from baseline until July 31, 2022. The CCA inter-adventitial diameter was measured using ultrasound. Cox proportional-hazard models were employed to explore the relationship between the common carotid artery diameter and cardiovascular mortality.

Results

At baseline, the mean CCA diameter (mm) of subjects was 7.30 ± 0.99 and increased significantly with age, ranging from 6.65 ± 0.71 among people 40–49 years to 7.99 ± 1.04 among people ≥ 80 years. CCA diameter was significantly larger in males compared to females (7.51 ± 1.03 versus vs. 7.16 ± 0.94; P < 0.001). A total of 185 participants died of CVD during a median follow-up of 4.48 years. CCA diameters were divided into quartiles, and the highest quartile of carotid diameter (≥ 8.06 mm) had a 2.29 (95% confidence interval [CI]: 1.24, 4.22) times higher risk of CVD mortality than the lowest quartile (≤ 6.65 mm) (P < 0.01) in the fully adjusted model. Each increase in the diameter of the common carotid artery (per SD) raised the risk of cardiovascular death by 36% (hazard ratio [HR]: 1.36; 95% CI: 1.18, 1.57). The subgroup analysis results demonstrated that a per SD increase was associated with a 42% increased risk of CVD mortality in participants aged ≥ 64 years in the fully adjusted model (HR: 1.42; 95%CI: 1.21, 1.66).

Conclusions

Our study indicates the possible incremental value of CCA diameter in optimizing the risk stratification of cardiovascular disease and provides essential insights into reducing the burden of cardiovascular disease.
Hinweise
Ziyi Yin and Jiajing Guo contributed equally to this work.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
CCA
Common carotid artery
CVD
Cardiovascular disease
HR
Hazard ratio
CI
Confidence interval
IMT
Intima-media thickness
CHD
Coronary heart disease
SBP
Systolic blood pressure
DBP
Diastolic blood pressure
TC
Total cholesterol
TG
Triglyceride
HDL-C
High-density lipoprotein cholesterol
LDL-C
Low-density lipoprotein cholesterol

Introduction

Cardiovascular disease (CVD) persists as the foremost cause of premature mortality and disability, exerting a substantial toll on healthcare systems and societal productivity [1, 2]. Globally, CVD is responsible for roughly 33% of all deaths [3], with China exhibiting the highest cardiovascular disease mortality rates worldwide [4]. Consequently, a thorough comprehension of the risk stratification for CVD is imperative for enhancing preventive measures and mitigating adverse outcomes.
CCA diameter, measured on ultrasound images as the distance between adventitia interfaces, is believed to increase due to hypertension and may correlate with growing arterial wall thickness [5]. While numerous prior studies have concentrated on assessing the intima-media thickness (IMT) of the common carotid artery [6, 7], some investigations have highlighted that an increased common carotid diameter is independently linked to various cardiovascular risk factors. Moreover, it has been suggested that the common carotid diameter could offer more predictive value for all-cause mortality than IMT [810]. A comprehensive meta-analysis involving four cohort studies in Western countries has indicated that a larger carotid artery diameter may be associated with an increased risk of CVD mortality [11]. Unfortunately, few studies have explored the relationship between CCA diameter and CVD mortality within Asian populations, particularly in northeast China. Hence, it is imperative to undertake a study in northeastern China to unravel the connection between CCA enlargement and the risk of CVD mortality, potentially enhancing prognostic insights for individuals with CVD.
In this study, our objective was to assess the association between CCA enlargement and CVD mortality in a diverse general population in northeastern China through a prospective community-based cohort study. Additionally, we aimed to delve into the potential of CCA in optimizing CVD risk stratification in these specific regions.

Methods

Study population

This population-based prospective cohort study comprised individuals from two counties in northeast China, as illustrated in Fig. 1. A total of 6,830 participants aged 40 years and above were initially recruited from 13 villages in Liaoning Province between September 2017 and May 2018. However, only 5,838 participants completed the study during this period. Baseline carotid ultrasound images were obtained, and 170 subjects with ineligible images were subsequently excluded. Ultimately, 5668 participants were included in the study, and detailed characteristics are presented in Table 1. A follow-up period of approximately 5 years was conducted to monitor the survival or death status of these participants until July 31, 2022. The study adhered to the ethical standards outlined in the 1964 Declaration of Helsinki and received approval from the Central Ethics Committee of the China National Center for Cardiovascular Disease. All participants provided written informed consent.
Table 1
Characteristics of the study population
Characteristics
Total (n = 5668)
Carotid Diameter Quartiles, mm
Q1 (≤ 6.65, n = 1609)
Q2 (6.66–7.25, n = 1423)
Q3 (7.26–8.05, n = 1476)
Q4 (≥ 8.06, n = 1160)
Age (x), y
58.9 ± 10.1
52.9 ± 8.5
57.0 ± 9.0
61.7 ± 9.6
65.8 ± 8.5
Sex, n (%)
 Male
2218 (39.1)
469 (29.1)
522 (36.7)
633 (42.9)
594 (51.2)
 Female
3450 (60.9)
1140 (70.9)
901 (63.3)
843 (57.1)
566 (48.8)
Education level, n (%)
 Primary school or lower
3256 (57.4)
748 (46.5)
807 (56.7)
900 (61.0)
801 (69.1)
 Middle school
1783 (31.5)
631 (39.2)
457 (32.1)
420 (28.5)
275 (23.7)
 High school or above
629 (11.1)
230 (14.3)
159 (11.2)
156 (10.6)
84 (7.2)
Income (CNY), n (%)
 < 5000
2041 (36.0)
410 (25.5)
467 (32.8)
593 (40.2)
571 (49.2)
 5000–9999
1327 (23.4)
365 (22.7)
330 (23.2)
352 (23.8)
280 (24.1)
 10,000–19,999
1146 (20.2)
385 (23.9)
310 (21.8)
266 (18.0)
185 (15.9)
 >= 20,000
1154 (20.4)
449 (27.9)
316 (22.2)
265 (18.0)
124 (10.7)
Heart Rate, bpm
72.9 ± 12.8
71.5 ± 11.4
72.3 ± 12.1
74.0 ± 13.6
74.1 ± 14.2
Body mass index, kg/m2
24.7 ± 3.8
24.5 ± 3.7
25.0 ± 3.6
24.6 ± 3.7
24.8 ± 4.0
Current smoking, n (%)
1458 (25.7)
338 (21.0)
364 (25.6)
411 (27.8)
345 (29.7)
History of stroke, n (%)
349 (6.2)
40 (2.5)
84 (5.9)
118 (8.0)
107 (9.2)
History of CHD, n (%)
175 (3.1)
22 (1.4)
36 (2.5)
67 (4.5)
50 (4.3)
Atrial fibrillation, n (%)
61 (1.1)
8 (0.5)
11 (0.8)
16 (1.1)
26 (2.2)
Hypertension, n (%)
3245 (57.3)
600 (37.3)
780 (54.8)
966 (65.4)
899 (77.5)
SBP, mmHg
141.6 ± 22.8
131.2 ± 19.5
139.0 ± 21.0
146.0 ± 22.5
153.6 ± 22.6
DBP, mmHg
87.3 ± 11.8
83.9 ± 10.7
86.8 ± 11.2
88.8 ± 12.1
90.5 ± 12.2
Diabetes mellitus, n (%)
713 (12.6)
141 (8.8)
187 (13.1)
210 (14.2)
175 (15.1)
TC (mmol/L)
5.0 ± 1.0
4.9 ± 1.0
5.0 ± 1.1
5.0 ± 1.0
5.0 ± 1.0
TG (mmol/L)
1.5 ± 1.2
1.4 ± 0.9
1.5 ± 1.3
1.6 ± 1.3
1.5 ± 1.1
HDL-C (mmol/L)
2.3 ± 0.7
2.2 ± 0.67
2.3 ± 0.7
2.4 ± 0.7
2.4 ± 0.7
LDL-C (mmol/L)
2.0 ± 0.9
2.0 ± 0.9
2.0 ± 0.9
1.9 ± 0.9
2.0 ± 0.9
Continuous variables are expressed as mean ± standard deviation (SD) and categorical variables as number (%)
CNY Chinese yuan (1CNY = 0.15 USD), CHD Coronary heart disease, SBP Systolic blood pressure, DBP Diastolic blood pressure, TC Total cholesterol, TG Triglyceride, HDL-C High-density lipoprotein cholesterol, LDL-C Low-density lipoprotein cholesterol

Demographic and clinical data

All participants completed a questionnaire covering demographic variables (such as age, sex, education, and income), smoking habits, and disease history (including stroke, coronary heart disease, atrial fibrillation, hypertension, and diabetes) during baseline interviews. Clinical examinations included measurements of heart rate, body mass index, blood lipid levels, and blood pressure levels. Previously established data collection methods and definitions were employed, including criteria for current smoking, hypertension, and diabetes.

Carotid ultrasonography

Participants underwent carotid duplex ultrasonography using a high-resolution ultrasonography device (Mindray M7, Shenzhen, China) equipped with a broadband 7L4S linear array transducer. The measurements were conducted by highly trained and certified sonographers with over 3 years of experience in vascular ultrasound imaging. Rigorous training of team members was conducted before data collection. Subjects were examined in a supine position, and both sides of the carotid arteries were scanned.
At diastole, CCA diameter between the adventitia interfaces was imaged along the long axis of the vessel (1–1.5 cm segment proximal to the dilation of the carotid bulb). The diameter value was recorded as the average value of the left and right carotid, and the mean value of both sides was used for statistical analysis. Intra-reader reliability was assessed in 50 randomly selected subjects from all participants. CCA diameters were examined twice in a blind manner with an interval of 1 week.

Ascertainment of outcomes

We obtained information about death, including the date and cause of death, from the National Population Registry of the China National Statistical Office. Mortality outcomes were assessed during the follow-up from the baseline examination until the date of death or July 31, 2022. Death certificates were obtained from the local health authorities. Cardiovascular disease mortality was defined by the International Classification of Diseases version 10 (ICD-10) codes I00 to I78 [12]. The underlying cause of death was initially verified independently by two internists, and any disagreements were resolved through joint determination with a third internist.

Statistical analysis

The baseline characteristics of participants are presented as the mean ± standard deviation (SD) for continuous variables with a normal distribution and as frequency (percentage) for classified variables. Group differences for continuous variables were assessed using the t-test. Reliability was evaluated by the intraclass correlation coefficient (ICC). The paired t-test was applied to examine differences between the two measurements.
Cox proportional-hazard models were utilized to explore the association between CCA diameter at baseline and the risk of CVD mortality. Additionally, CCA diameter was categorized into quartiles (Q), where Q1 represented the lowest quartile and Q4 the highest. The specific ranges for CCA diameters were as follows: Q1 (≤ 6.65 mm), Q2 (6.66–7.25 mm), Q3 (7.26–8.05 mm), and Q4 (≥ 8.06 mm) (Table 1). Cardiovascular disease mortality was calculated based on quartiles of carotid artery diameter. Kaplan-Meier curves were employed to compare CVD mortality risk stratified by CCA diameter quartile, followed by a log-rank test.
Furthermore, the analyses were conducted in three models: model 1 was unadjusted; model 2 was adjusted for sex and age; and model 3 was further adjusted for education level, income, heart rate, body mass index, smoking, history of stroke, history of coronary heart disease, atrial fibrillation, systolic blood pressure, diabetes, total cholesterol (TC), triglyceride (TG), high-density lipoprotein cholesterol (HDL-C), and low-density lipoprotein cholesterol (LDL-C). All Cox regression analyses adhered to the proportionality assumption. SPSS version 24.0 (IBM Corporation, Armonk, NY, USA) was employed for data processing and analysis. A two-tailed P < 0.05 indicated statistical significance for all analyses, and estimates were expressed as a 95% CI.

Results

Population characteristics at baseline

Table 1 presents the baseline characteristics of the study population and carotid diameter quartiles. The study included 5668 participants, comprising 2218 males (39.1%) and 3450 females (60.9%). The mean age of the population was 58.9 ± 10.1 years. Approximately 57.4% of participants had an education level of primary school or lower, and 36.0% reported a household income of less than 5000 yuan (approximately $700) per year. Among the participants, 25.7% were current smokers, 57.3% had hypertension, and 12.6% had diabetes.

Characteristic of CCA diameter at baseline

The average CCA diameter by sex and age is summarized in Table 2. The average CCA diameter (mm) was 7.30 ± 0.99, exhibiting a significant increase with age. The diameter ranged from 6.65 ± 0.71 in the 40–49 age group to 7.99 ± 1.04 in the group aged 80 years or older. Additionally, the CCA diameter in males was significantly larger than that in females (7.51 ± 1.03 mm vs. 7.16 ± 0.94 mm; P < 0.001). Among males, the CCA diameter increased from 6.86 ± 0.76 mm in the 40–49 age group to 8.06 ± 1.04 mm in those aged ≥ 80 years. Among females, the CCA diameter increased from 6.56 ± 0.67 mm in the 40–49 age group to 7.94 ± 1.05 mm in those aged ≥ 80 years.
Table 2
The average CCA (mm) by sex and age
Age, years
Men
Women
Total
P value
40–49
6.86 ± 0.76
6.56 ± 0.67
6.65 ± 0.71
< 0.001
50–59
7.26 ± 0.87
6.90 ± 0.79
7.03 ± 0.84
< 0.001
60–69
7.73 ± 1.03
7.57 ± 0.88
7.64 ± 0.95
< 0.001
70–79
8.09 ± 1.04
7.87 ± 0.89
7.97 ± 0.97
0.002
≥ 80
8.06 ± 1.04
7.94 ± 1.05
7.99 ± 1.04
0.470
Total
7.51 ± 1.03
7.16 ± 0.94
7.30 ± 0.99
< 0.001
Continuous variables are expressed as mean ± standard deviation (SD)
CCA Common carotid artery
The ICC between the initial and subsequent CCA measurements, conducted with a 1-week interval for 50 participants, was found to be 0.92 (P < 0.001). This excellent ICC value indicates high reliability. The mean difference between the measurements was 0.062 ± 0.25 mm (P = 0.085).

Association between CCA diameter and cardiovascular disease

During the median follow-up of 4.48 years, a total of 185 participant died of cardiovascular disease. The cumulative CVD mortality rate increased with the rise in CCA diameter, reaching 7.4% in the highest quartile (Q4) compared to 0.9% in the lowest quartile (Q1).
Cox proportional-hazard models were employed to investigate the relationship between CCA diameter and CVD mortality. Individuals in the highest quartile of carotid diameter (diameter ≥ 8.06 mm), compared with those in the lowest quartile (diameter ≤ 6.65 mm), had a substantially higher risk of developing adverse outcomes related to cardiovascular disease (model1: HR: 8.75; 95% CI: 4.98–15.40). In the fully adjusted model, the risk of CVD mortality in the highest quartile (Q4) was 2.29 times higher (95% CI: 1.24, 4.22) than that in the lowest quartile (Q1). Additionally, a per 1 SD increase in the diameter of the common carotid artery (per standard deviation) was associated with a 36% increased risk of CVD mortality (HR: 1.36; 95% CI: 1.18–1.57) (Table 3).
Table 3
Association between baseline CCA and the risk of CVD mortality
CCA quartiles
CVD mortality/participants
Model 1
Model 2
Model 3
HR (95% CI)
P value
HR (95% CI)
P value
HR (95% CI)
P value
Q1: <= 6.65 mm
14/1609
Reference
 
Reference
 
Reference
 
Q2: 6.66–7.25 mm
29/1423
2.33 (1.23, 4.41)
0.009
1.54 (0.81, 2.92)
0.188
1.50 (0.78, 2.91)
0.226
Q3: 7.26–8.05 mm
56/1476
4.38 (2.44, 7.86)
< 0.001
1.70 (0.93, 3.09)
0.083
1.57 (0.84, 2.93)
0.160
Q4: >= 8.06 mm
86/1160
8.75 (4.98, 15.40)
< 0.001
2.59 (1.45, 4.64)
0.001
2.29 (1.24, 4.22)
< 0.01
Per SD increase
185/5668
1.95 (1.73, 2.19)
< 0.001
1.40 (1.22, 1.61)
< 0.001
1.36 (1.18, 1.57)
< 0.001
CCA Common carotid artery, CVD Cardiovascular disease, Q Quartile, HR Hazard ratio, CI Confidence interval
Model 1: unadjusted, Model 2: adjusted for sex and age, Model 3: further adjusted for education level, income, heart rate, body mass index, smoking, history of stroke, history of coronary heart disease, atrial fibrillation, systolic blood pressure, diabetes, total cholesterol, triglyceride, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol
The results of subgroup analysis revealed a higher number of CVD deaths in age tertile 3 (142/1837) compared to tertile 1 (14/1915) and tertile 2 (29/1916). A per SD increase was associated with a 42% increased risk of CVD mortality in participants aged ≥ 64 years (HR: 1.42; 95% CI: 1.21, 1.66), indicating an increased risk in the older age group. The association between baseline CCA and the risk of CVD mortality was statistically significant only in the older age group (age tertile 3) (Table 4). The Kaplan-Meier curves depicted that the risk of cardiovascular disease mortality in the highest quartile (Q4) was the highest among all quartiles, and this pattern persisted when stratified by age tertiles (Fig. 2).
Table 4
Association between CCA quartiles and CVD mortality risk, stratified by age tertiles
CCA quartiles
CVD mortality/participants
Model 1
Model 2
Model 3
HR (95% CI)
P value
HR (95% CI)
P value
HR (95% CI)
P value
Age tertile 1: ≤ 53 y
 Q1: <= 6.20 mm
2/484
Reference
 
Reference
 
Reference
 
 Q2: 6.21–6.70 mm
1/487
0.49 (0.04, 5.39)
0.558
0.43 (0.04, 4.78)
0.494
0.45 (0.04, 5.31)
0.527
 Q3: 6.71–7.15 mm
3/487
1.46 (0.24, 8.73)
0.679
1.13 (0.19, 6.90)
0.893
0.98 (0.15, 6.26)
0.979
 Q4: >= 7.16 mm
8/457
4.08 (0.87, 19.25)
0.075
2.81 (0.57, 13.71)
0.202
1.69 (0.29, 10.0)
0.562
 Per SD increase
14/1915
1.75 (1.23, 2.49)
< 0.01
1.64 (1.10, 2.46)
< 0.001
1.54 (0.91, 2.63)
0.11
Age tertile 2: 54–63 y
 Q1: <= 6.70 mm
2/483
Reference
 
Reference
 
Reference
 
 Q2: 6.71–7.25 mm
6/536
2.71 (0.55, 13.41)
0.223
2.29 (0.46, 11.39)
0.31
1.57 (0.31, 8.08)
0.588
 Q3: 7.26–7.87 mm
12/418
6.95 (1.56, 31.05)
0.011
5.48 (1.22, 24.62)
0.026
4.61 (0.98, 21.74)
0.053
 Q4: >= 7.88 mm
9/479
4.53 (0.98, 20.96)
0.053
2.97 (0.63, 13.99)
0.168
1.51 (0.29, 7.73)
0.624
 Per SD increase
29/1916
1.53 (1.10, 2.13)
0.012
1.32 (0.94, 1.87)
0.112
1.18 (0.80, 1.75)
0.41
Age tertile 3: ≥ 64 y
 Q1: <= 7.25 mm
29/500
Reference
 
Reference
 
Reference
 
 Q2: 7.26–7.80 mm
26/448
0.99 (0.58, 1.68)
0.969
0.85 (0.50, 1.45)
0.55
0.85 (0.49, 1.47)
0.558
 Q3: 7.81–8.50 mm
30/428
1.23 (0.74, 2.05)
0.425
1.10 (0.66, 1.83)
0.724
1.05 (0.62, 1.78)
0.853
 Q4: >= 8.51 mm
57/461
2.18 (1.40, 3.41)
0.001
1.88 (1.20, 2.95)
0.006
1.92 (1.19, 3.08)
0.007
 Per SD increase
142/1837
1.44 (1.24, 1.67)
< 0.001
1.39 (1.20, 1.62)
< 0.001
1.42 (1.21, 1.66)
< 0.001
CCA Common carotid artery, CVD Cardiovascular disease, Q Quartile, HR Hazard ratio, CI Confidence interval
Model 1: unadjusted, Model 2: adjusted for sex and age, Model 3: further adjusted for education level, income, heart rate, body mass index, smoking, history of stroke, history of coronary heart disease, atrial fibrillation, systolic blood pressure, diabetes, total cholesterol, triglyceride, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol

Discussion

In this cohort study, we identified a significant relationship between the diameter of the CCA and CVD mortality in a population from northeast China. Our findings demonstrated that enlargement of CCA diameter was associated with an increased risk of death from cardiovascular disease. This suggests that CCA diameter serves as a crucial predictive factor for the risk of CVD mortality, surpassing the predictive capacity of traditional clinical risk factors. Therefore, the assessment of CCA diameter provides possible independent and incremental value in predicting the prognosis of cardiovascular disease.
Cardiovascular diseases encompass conditions such as coronary heart disease and stroke [13]. A prior study indicated that an enlarged CCA diameter was linked to a higher prevalence of cardiovascular events [11]. Moreover, our previous research demonstrated a positive association between CCA diameter and the prevalence of stroke [14, 15]. These findings align with the results of the present study. However, the association between CCA diameter and CVD mortality was not explored in those studies, leaving the prognostic value of CCA for CVD unclear. Additionally, a retrospective cohort study conducted in Taiwan, China, reported an independent association between reduced CCA diameter and CVD mortality [16]. This finding contrasts with our results. However, the retrospective nature of their study may introduce classification errors and data inaccuracies, making our results more reliable.
Several other studies have also suggested that an enlarged CCA increases the risk of CVD mortality. A case-control study showed that in postmenopausal women, the diameter of the CCA was larger in subjects with atherosclerosis than in those without [17]. CCA enlargement might serve as compensation for atherosclerotic lesions. As plaque volume increased, the carotid segment expanded, and the interplay between these processes compensated for arterial stenosis in the early stages of the disease [18]. Atherosclerosis is considered a primary cause of cardiovascular disease [19], and this finding is consistent with ours, confirming that CCA enlargement is associated with CVD. Another study demonstrated that carotid enlargement is a valid predictor of adverse cardiovascular events [20]. Therefore, carotid diameter contributes to identifying individuals at high cardiovascular risk and provides an effective means to monitor the prognosis of cardiovascular disease.
Nonetheless, the findings of the present study suggest a departure from a linear association between CCA diameter and CVD mortality in individuals under 64 years of age. The correlation between CCA diameter and CVD mortality is intricately tied to age, with distinct patterns observed in the younger group. Within the younger cohort, the risk of CVD mortality appears comparatively low, possibly attributed to a more favorable physiological state. Furthermore, the progression and eventual occurrence of CVD-related mortality typically unfold gradually over an extended period. The limited number of CVD mortality events within this subgroup has, however, posed a challenge to detecting a statistically significant association. To arrive at more definitive conclusions, it is imperative to embark on further investigations incorporating a longer-term follow-up and larger sample sizes. This approach will provide a more comprehensive understanding of the intricate interplay between CCA diameter and CVD mortality, particularly in the context of age-related dynamics.
Cardiovascular disease stands as one of the leading causes of death and disability-adjusted life years worldwide. The rise in CVD deaths is fueled by population growth and aging, particularly in South and East Asian countries with large and expanding populations [3]. Consequently, there is a need for more research on cardiovascular disease in Asia. Our study builds upon previous research [21, 22]. Clinicians can utilize the findings of these studies to assess the degree of CCA enlargement, enabling them to grade the severity of the disease and administer appropriate treatment. Thus, the present study holds significant value for monitoring and preventing adverse cardiovascular outcomes in the general population in northeast China.
Nevertheless, our study has certain limitations that need consideration. First, we relied on a single baseline measurement of covariates, and some of these variables may have changed over time, potentially introducing bias toward null values. Second, many previous studies have explored the relationship between IMT and cardiovascular events, but the results vary due to different measurement methods, follow-up time, and populations [57, 20]. Therefore, this study mainly focused on the change of the CCA diameter, we did not include IMT in the present study, however, we intend to investigate IMT and other parameters after longer follow-up in the future. Third, our study population was drawn from rural areas in northeast China; hence, further research in diverse regions is essential to enhance our understanding of the relationship between CCA diameter and cardiovascular disease mortality.

Conclusion

In conclusion, our study highlights a substantial association between CCA diameter and CVD mortality in a population from northeast China. Specifically, enlargement of CCA diameter appears to be linked to an increased risk of death from cardiovascular disease, especially in the elderly individuals. However, the relationship between CCA diameter and CVD mortality does not exhibit an obvious linear pattern in the younger population, a longer-term follow-up and larger sample sizes are required. Moreover, our findings propose that CCA diameter serves as a possible predictor of CVD prognosis and offers potential incremental value in refining the risk stratification of cardiovascular disease. This information could be crucial in efforts to mitigate the burden of cardiovascular disease in China.

Acknowledgements

We thank the staff from the central hospital and CDC of Chaoyang City and Lingyuan City in Liaoning Province who worked hard to ensure the reliability and accuracy of the data.

Declarations

The study was performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and was granted approval by the Central Ethics Committee at the China National Center for Cardiovascular Disease (Clinical Research No.[2015]024. Beijing, China.). All methods were performed in accordance with the relevant guidelines and regulations. Written informed consent was obtained from all participants.
Not applicable.

Competing interests

The authors declare no competing interests.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396:1204–22.CrossRef GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396:1204–22.CrossRef
2.
Zurück zum Zitat Zhao D, Liu J, Wang M, Zhang X, Zhou M. Epidemiology of cardiovascular disease in China: current features and implications. Nat Rev Cardiol. 2019;16:203–12.CrossRefPubMed Zhao D, Liu J, Wang M, Zhang X, Zhou M. Epidemiology of cardiovascular disease in China: current features and implications. Nat Rev Cardiol. 2019;16:203–12.CrossRefPubMed
3.
Zurück zum Zitat Joseph P, Leong D, McKee M, Anand SS, Schwalm J-D, Teo K, et al. Reducing the global burden of cardiovascular disease, part 1: the epidemiology and risk factors. Circ Res. 2017;121:677–94.CrossRefPubMed Joseph P, Leong D, McKee M, Anand SS, Schwalm J-D, Teo K, et al. Reducing the global burden of cardiovascular disease, part 1: the epidemiology and risk factors. Circ Res. 2017;121:677–94.CrossRefPubMed
4.
Zurück zum Zitat Roth GA, Mensah GA, Fuster V. The global burden of cardiovascular diseases and risks. J Am Coll Cardiol. 2020;76:2980–1.CrossRefPubMed Roth GA, Mensah GA, Fuster V. The global burden of cardiovascular diseases and risks. J Am Coll Cardiol. 2020;76:2980–1.CrossRefPubMed
5.
Zurück zum Zitat Polak JF, Kronmal RA, Tell GS, O’Leary DH, Savage PJ, Gardin JM, et al. Compensatory increase in common carotid artery diameter: relation to blood pressure and artery intima-media thickness in older adults. Stroke. 1996;27:2012–5.CrossRefPubMed Polak JF, Kronmal RA, Tell GS, O’Leary DH, Savage PJ, Gardin JM, et al. Compensatory increase in common carotid artery diameter: relation to blood pressure and artery intima-media thickness in older adults. Stroke. 1996;27:2012–5.CrossRefPubMed
6.
Zurück zum Zitat Bots ML, Dijk JM, Oren A, Grobbee DE. Carotid intima–media thickness, arterial stiffness and risk of cardiovascular disease: current evidence. J Hypertens. 2002;20:2317–25.CrossRefPubMed Bots ML, Dijk JM, Oren A, Grobbee DE. Carotid intima–media thickness, arterial stiffness and risk of cardiovascular disease: current evidence. J Hypertens. 2002;20:2317–25.CrossRefPubMed
7.
Zurück zum Zitat Simon A, Gariepy J, Chironi G, Megnien J-L, Levenson J. Intima–media thickness: a new tool for diagnosis and treatment of cardiovascular risk. J Hypertens. 2002;20:159–69.CrossRefPubMed Simon A, Gariepy J, Chironi G, Megnien J-L, Levenson J. Intima–media thickness: a new tool for diagnosis and treatment of cardiovascular risk. J Hypertens. 2002;20:159–69.CrossRefPubMed
8.
Zurück zum Zitat Bonithon-Kopp C, Touboul PJ, Berr C, Magne C, Ducimetière P. Factors of carotid arterial enlargement in a population aged 59 to 71 years: the EVA study. Stroke. 1996;27:654–60.CrossRefPubMed Bonithon-Kopp C, Touboul PJ, Berr C, Magne C, Ducimetière P. Factors of carotid arterial enlargement in a population aged 59 to 71 years: the EVA study. Stroke. 1996;27:654–60.CrossRefPubMed
9.
Zurück zum Zitat Kawamoto R, Tomita H, Oka Y, Ohtsuka N. Association between risk factors and carotid enlargement. Intern Med. 2006;45:503–9.CrossRefPubMed Kawamoto R, Tomita H, Oka Y, Ohtsuka N. Association between risk factors and carotid enlargement. Intern Med. 2006;45:503–9.CrossRefPubMed
10.
Zurück zum Zitat Fritze F, Groß S, Ittermann T, Völzke H, Felix SB, Schminke U, et al. Carotid lumen diameter is associated with all-cause mortality in the general population. JAHA. 2020;9:e015630.CrossRefPubMedPubMedCentral Fritze F, Groß S, Ittermann T, Völzke H, Felix SB, Schminke U, et al. Carotid lumen diameter is associated with all-cause mortality in the general population. JAHA. 2020;9:e015630.CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Sedaghat S, van Sloten TT, Laurent S, London GM, Pannier B, Kavousi M, et al. Common carotid artery diameter and risk of cardiovascular events and mortality: pooled analyses of four cohort studies. Hypertension. 2018;72:85–92.CrossRefPubMed Sedaghat S, van Sloten TT, Laurent S, London GM, Pannier B, Kavousi M, et al. Common carotid artery diameter and risk of cardiovascular events and mortality: pooled analyses of four cohort studies. Hypertension. 2018;72:85–92.CrossRefPubMed
12.
Zurück zum Zitat Anderson RN, Miniño AM, Hoyert DL, Rosenberg HM. Comparability of cause of death between ICD-9 and ICD-10: preliminary estimates. Natl Vital Stat Rep. 2001;49:1–32.PubMed Anderson RN, Miniño AM, Hoyert DL, Rosenberg HM. Comparability of cause of death between ICD-9 and ICD-10: preliminary estimates. Natl Vital Stat Rep. 2001;49:1–32.PubMed
13.
Zurück zum Zitat Xu Y-J, Zhang M, Ji L, Elimban V, Chen L, Dhalla NS. Suppression of high lipid diet induced by atherosclerosis sarpogrelate. J Cell Mol Med. 2012;16:2394–400.CrossRefPubMedPubMedCentral Xu Y-J, Zhang M, Ji L, Elimban V, Chen L, Dhalla NS. Suppression of high lipid diet induced by atherosclerosis sarpogrelate. J Cell Mol Med. 2012;16:2394–400.CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Xue W, Tian Y, Jing L, Li R, Li G, Li D, et al. Sex difference in the correlation between carotid artery diameter and prevalence of stroke: Insights from a Chinese population. Int J Cardiol. 2022;353:103–8.CrossRefPubMed Xue W, Tian Y, Jing L, Li R, Li G, Li D, et al. Sex difference in the correlation between carotid artery diameter and prevalence of stroke: Insights from a Chinese population. Int J Cardiol. 2022;353:103–8.CrossRefPubMed
15.
Zurück zum Zitat Xue W, Tian Y, Jing L, Li G, Yan H, Zhang B, et al. Sex-specific prediction value of common carotid artery diameter for stroke risk in a hypertensive population: a cross-sectional study. Quant Imaging Med Surg. 2022;12:1428–37.CrossRefPubMedPubMedCentral Xue W, Tian Y, Jing L, Li G, Yan H, Zhang B, et al. Sex-specific prediction value of common carotid artery diameter for stroke risk in a hypertensive population: a cross-sectional study. Quant Imaging Med Surg. 2022;12:1428–37.CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Chen P, Lin F, Huang H, Chiang H, Chang S, Chen P, et al. Diameter reduction determined through carotid ultrasound associated with cardiovascular and all-cause mortality: a single-center experience of 38 201 consecutive patients in Taiwan. JAHA. 2021;10:e023689.CrossRefPubMedPubMedCentral Chen P, Lin F, Huang H, Chiang H, Chang S, Chen P, et al. Diameter reduction determined through carotid ultrasound associated with cardiovascular and all-cause mortality: a single-center experience of 38 201 consecutive patients in Taiwan. JAHA. 2021;10:e023689.CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Montalcini T, Gorgone G, Gazzaruso C, Sesti G, Perticone F, Pujia A. Large brachial and common carotid artery diameter in postmenopausal women with carotid atherosclerosis. Atherosclerosis. 2008;196:443–8.CrossRefPubMed Montalcini T, Gorgone G, Gazzaruso C, Sesti G, Perticone F, Pujia A. Large brachial and common carotid artery diameter in postmenopausal women with carotid atherosclerosis. Atherosclerosis. 2008;196:443–8.CrossRefPubMed
18.
Zurück zum Zitat Steinke W, Els T, Hennerici M. Compensatory carotid artery dilatation in early atherosclerosis. Circulation. 1994;89:2578–81.CrossRefPubMed Steinke W, Els T, Hennerici M. Compensatory carotid artery dilatation in early atherosclerosis. Circulation. 1994;89:2578–81.CrossRefPubMed
20.
Zurück zum Zitat Polak JF, Sacco RL, Post WS, Vaidya D, Arnan MK, O’Leary DH. Incident stroke is associated with common carotid artery diameter and not common carotid artery intima-media thickness. Stroke. 2014;45:1442–6.CrossRefPubMedPubMedCentral Polak JF, Sacco RL, Post WS, Vaidya D, Arnan MK, O’Leary DH. Incident stroke is associated with common carotid artery diameter and not common carotid artery intima-media thickness. Stroke. 2014;45:1442–6.CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Meng R, Yu C, Liu N, He M, Lv J, Guo Y, et al. Association of depression with all-cause and cardiovascular disease mortality among adults in China. JAMA Netw Open. 2020;3:e1921043.CrossRefPubMedPubMedCentral Meng R, Yu C, Liu N, He M, Lv J, Guo Y, et al. Association of depression with all-cause and cardiovascular disease mortality among adults in China. JAMA Netw Open. 2020;3:e1921043.CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Joseph P, Kutty VR, Mohan V, Kumar R, Mony P, Vijayakumar K, et al. Cardiovascular disease, mortality, and their associations with modifiable risk factors in a multi-national South Asia cohort: a PURE substudy. Eur Heart J. 2022;43:2831–40.CrossRefPubMed Joseph P, Kutty VR, Mohan V, Kumar R, Mony P, Vijayakumar K, et al. Cardiovascular disease, mortality, and their associations with modifiable risk factors in a multi-national South Asia cohort: a PURE substudy. Eur Heart J. 2022;43:2831–40.CrossRefPubMed
Metadaten
Titel
Common carotid artery diameter and the risk of cardiovascular disease mortality: a prospective cohort study in northeast China
verfasst von
Ziyi Yin
Jiajing Guo
Ru Li
Hong Zhou
Xue Zhang
Shanshan Guan
Yuanmeng Tian
Li Jing
Qun Sun
Guangxiao Li
Liying Xing
Shuang Liu
Publikationsdatum
01.12.2024
Verlag
BioMed Central
Erschienen in
BMC Public Health / Ausgabe 1/2024
Elektronische ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-024-17749-x

Weitere Artikel der Ausgabe 1/2024

BMC Public Health 1/2024 Zur Ausgabe